Projected outcomes of 6-month delay in exception points versus an equivalent Model for End-Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates-Reference-Cited by-同舟云学术

Projected outcomes of 6-month delay in exception points versus an equivalent Model for End-Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates

Published:2016-09-26 Issue:10 Volume:22 Page:1343-1355
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Alver Sarah K.¹,Lorenz Douglas J.¹,Marvin Michael R.²,Brock Guy N.¹

Affiliation:

1. Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences; University of Louisville; Louisville KY

2. Department of Transplantation and Liver Surgery; Geisinger Medical Center; Danville PA

Funder

Health Resources and Services Administration

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference19 articles.

1. https://optn.transplant.hrsa.gov/governance/policies/

2. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system;Washburn;Am J Transplant,2010

3. Increasing disparity in waitlist mortality rates with increased Model for End-Stage Liver Disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma;Goldberg;Liver Transpl,2012

4. https://optn.transplant.hrsa.gov/news/revised-liver-policy-regarding-hcc-exception-scores/

5. Waiting list removal rates among patients with chronic and malignant liver diseases;Freeman;Am J Transplant,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous Risk Score Predicts Waitlist and Post-transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes;Clinical Gastroenterology and Hepatology;2024-06

2. Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma;Cancers;2024-01-02

3. Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma;JHEP Reports;2023-12

4. Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy;Liver Transplantation;2023-05-03

5. Outcomes and Patient Selection in Laparoscopic vs. Open Liver Resection for HCC and Colorectal Cancer Liver Metastasis;Cancers;2023-02-12